UCB BioSciences GmbH
🇩🇪Germany
A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease
- First Posted Date
- 2007-11-01
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 403
- Registration Number
- NCT00552344
- Locations
- 🇺🇸
284, Lakewood, Colorado, United States
🇺🇸278, New Port Richey, Florida, United States
🇺🇸279, Louisville, Kentucky, United States
© Copyright 2024. All Rights Reserved by MedPath